Limiting ExcessiveSection 8 Damages Awards in Proceedings Under Canadian Patented Medicines Regulations
RESOLVED, that IPO supports that any section 8 damages awarded [...]
Patent-Fee-Setting-Comments
IPO Comments on USPTO Patent-Fee-Setting
IPO COMMENTS TO SIPO ON DRAFT PATENT EXAMINATION GUIDELINES
IPO Comments to SIPO on Draft Patent Examination Guidelines
IPO Comments to USPTO on Leveraging Electronic Resources to Retrieve Information from Applicant’s Other Applications and Streamline Patent Issuance
IPO Comments to USPTO on Leveraging Electronic Resources to Retrieve [...]
IPO Comments on Exceptions and Limitations for IP Rights
IPO Comments on Exceptions and Limitations for IP Rights
IPO Comments on “Changes in Requirements for Affidavits or Declarations of Use, Continued Use, or Excusable Nonuse in Trademark Cases,” 81 Fed. Reg. 120
IPO Comments on “Changes in Requirements for Affidavits or Declarations [...]
IPO Comments to Indian Patent Office on CRI Guidelines
IPO Comments to Indian Patent Office on CRI Guidelines
IPO Comments on SEC Concept Release re IP Disclosures
IPO Comments on SEC Concept Release re IP Disclosures
IPO Letter to USPTO re: Trademark Fees
IPO Letter to USPTO re: Trademark Fees
IPO Comments to USPTO re: Written Description for Design Patent Applications
IPO Comments to USPTO re: Written Description for Design Patent [...]